$1176.10
Price
$1.05T
Market Cap
40.0
P/E Ratio
24.9
Forward P/E
$29.40
EPS (TTM)
0.58%
Dividend Yield
$8.9B
Cash
$42.5B
Total Debt
892M
Shares Out
$712.05
$1292.65
52-Week Range
Institutional Ownership of Eli Lilly & Co
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| 431 | $516954 | — | — |
Trading Activity for Eli Lilly & Co
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | EXIT | — | — | $751.99 | |
| 2025-Q2 | |||||
| BUY | +13.2% | 1.5M | $1.2B | $769.88 | |
| SELL | EXIT | — | — | $769.88 | |
| SELL | EXIT | — | — | $769.88 | |
| 2025-Q1 | |||||
| BUY | +1.9% | 1.3M | $1.1B | $826.07 | |
| SELL | -29.5% | 551.8K | $456M | $826.07 | |
| BUY | +75.4% | 492.8K | $407M | $826.07 | |
| 2024-Q4 | |||||
| BUY | +35.1% | 1.3M | $1.0B | $811.81 | |
| BUY | NEW | 782.9K | $604M | $811.81 | |
| BUY | NEW | 281.0K | $217M | $811.81 | |
| 2024-Q3 | |||||
| BUY | +4.3% | 969.8K | $859M | $914.57 | |
| 2024-Q2 | |||||
| BUY | +4.5% | 930.0K | $842M | $777.77 | |
| 2023-Q4 | |||||
| SELL | -3.2% | 890.0K | $519M | $586.46 | |
| 2023-Q3 | |||||
| BUY | +26.9% | 919.1K | $494M | $538.00 | |
| 2023-Q2 | |||||
| BUY | NEW | 724.1K | $340M | $431.19 | |
| 2023-Q1 | |||||
| SELL | EXIT | — | — | $337.65 | |
| 2022-Q4 | |||||
| BUY | NEW | 192.1K | $45M | $360.01 | |
| SELL | EXIT | — | — | $360.01 | |
| 2021-Q3 | |||||
| SELL | EXIT | — | — | $243.50 | |
| 2021-Q2 | |||||
| SELL | -0.2% | 19.0K | $5M | $195.47 | |
| 2021-Q1 | |||||
| SELL | -0.2% | 19.0K | $5M | $201.44 | |
| 2020-Q4 | |||||
| BUY | +0.5% | 19.0K | $4M | $145.56 | |
| 2020-Q3 | |||||
| SELL | -0.1% | 19.0K | $4M | $152.29 | |
| BUY | NEW | 432 | $64000 | $152.29 | |
| 2020-Q2 | |||||
| SELL | -0.1% | 19.0K | $3M | $153.57 | |
| 2020-Q1 | |||||
| BUY | +17.6% | 19.0K | $2M | $139.58 | |
| 2019-Q1 | |||||
| SELL | EXIT | — | — | $120.89 | |
| 2018-Q4 | |||||
| SELL | -100.0% | 81 | $9000 | $112.11 | |
| 2018-Q3 | |||||
| SELL | -59.5% | 1.1M | $119M | $103.33 | |
| SELL | EXIT | — | — | $103.33 | |
| 2018-Q2 | |||||
| SELL | -26.1% | 2.7M | $234M | $82.22 | |
| BUY | NEW | 841.0K | $151M | $82.22 | |
| 2018-Q1 | |||||
| BUY | +28.7% | 3.7M | $287M | $78.75 | |
Insider Trading for Eli Lilly & Co
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.